For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230223:nRSW8261Qa&default-theme=true
RNS Number : 8261Q SigmaRoc PLC 23 February 2023
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED UNDER THE MARKET
ABUSE REGULATION (EU) NO. 596/2014 (AS IT FORMS PART OF UK LAW BY VIRTUE OF
THE EUROPEAN UNION (WITHDRAWAL) ACT 2018) AND THE INFORMATION CONTAINED HEREIN
IS NOT FOR PUBLICATION, RELEASE, OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN,
OR INTO, THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY
JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL. THE INFORMATION CONTAINED
HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN THE UNITED
STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION
IN WHICH THE SAME WOULD BE UNLAWFUL
THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE OR
CONTAIN ANY INVITATION, SOLICITATION, RECOMMENDATION, OFFER OR ADVICE TO ANY
PERSON TO SUBSCRIBE FOR, OTHERWISE ACQUIRE OR DISPOSE OF ANY SECURITIES IN
SIGMAROC PLC OR ANY OTHER ENTITY IN ANY SUCH JURISDICTION.
23 February 2023
(EPIC: SRC / Market: AIM / Sector: Construction Materials)
SIGMAROC PLC
('SigmaRoc', the 'Group' or the 'Company')
Results of Placing and REX Retail Offer
SigmaRoc (AIM: SRC), the quarried materials group, is pleased to announce the
successful completion of the Placing and REX Retail Offer announced yesterday
by the Company (the "Placing Announcement"), raising gross proceeds of
approximately £30 million.
The Company has placed, in aggregate, 55,555,555 new Ordinary Shares pursuant
to the Fundraising, each at a price of 54 pence per share, representing a
premium of approximately 1.8 per cent. to the mid-market closing price of 53
pence on 22 February 2023.
The Company consulted with and received strong support from many of its
largest shareholders prior to the Fundraising. Consistent with each of its
prior placings, the Company respected the principles of pre-emption, so far as
possible, through the allocation process, both in the Placing and the Retail
Offer. The Company's management team actively participated in the structuring
and allocation of the Fundraising.
The proceeds of the Fundraising will part fund ten potential near term
strategic acquisition opportunities and four organic growth and carbon
footprint reduction projects. Taken together, the Acquisitions and Organic
Investment Projects are anticipated, should they all complete, to generate
approximately £42 million of net revenue, £10 million of EBITDA and profit
after tax of £6 million on an annualised basis.
Director participation
Certain Directors and senior management of SigmaRoc have subscribed, in
aggregate, for 455,556 Placing Shares at the Placing Price and the table below
sets out each individual's allocation:
Name No. Ordinary Shares currently held Placing Shares subscribed for Holding following Admission % of issued share capital after Admission
David Barrett 3,053,439 265,741 3,319,180 0.48%
Max Vermorken 762,219 64,815 827,034 0.12%
Garth Palmer 616,146 55,556 671,702 0.10%
Charles Trigg 344,830 37,037 381,867 0.06%
Fons Vermorken 266,884 23,148 290,032 0.04%
Dean Masefield 78,868 9,259 88,127 0.01%
Max Vermorken, CEO of SigmaRoc, commented on the Fundraising as follows:
"I am pleased to see many of our existing shareholders continuing to support
SigmaRoc and our buy-and-build strategy. The strong level of demand from new
and existing investors underpins confidence in our plans for the future.
We have identified a strong pipeline of acquisitions as well as organic growth
opportunities that this funding will help us to deliver and we look forward to
updating our shareholders on our progress in due course."
Settlement and dealings
Application has been made to the London Stock Exchange for the Fundraising
Shares to be admitted to trading on AIM.
Admission is expected to take place, and dealings are expected to commence at
08.00 a.m. on 28 February 2023.
Total voting rights
In accordance with the provision of the Disclosure Guidance and Transparency
Rules of the FCA ('DTRs'), the Company confirms that, following Admission, its
issued share capital will comprise 693,801,899 Ordinary Shares. The Company
does not hold any Ordinary Shares in treasury. Therefore, the total voting
rights in the Company will be 693,801,899. This figure may be used by
Shareholders as the denominator for the calculations by which they will
determine if they are required to notify their interest in, or a change to
their interest in, the Company under the DTRs.
The Fundraising Shares will, following Admission, rank pari passu in all
respects with the existing Ordinary Shares.
Capitalised terms used in this announcement, unless otherwise defined herein,
have the same meaning as ascribed to them in the Placing Announcement.
For further information, please contact:
SigmaRoc plc Tel: +44 (0) 207 129 7828
Max Vermorken
Liberum Capital (Nomad and Joint Bookrunner) Tel: +44 (0) 203 100 2000
Nicholas How / Ben Cryer / Jamie Richards / Cara Murphy
Peel Hunt (Joint Bookrunner) Tel: +44 (0) 20 7418 8900
Investment Banking
Mike Bell / Ed Allsopp / Ben Harrington
Syndicate and Broking
Sohail Akbar / Jock Maxwell Macdonald / John Welch
Redburn (Joint Bookrunner) Tel: +44 (0) 20 7000 2020
Adam Young / Ben Glaeser
Market Abuse Regulation
The information contained within this announcement is deemed by the Company to
constitute inside information as stipulated under the Market Abuse Regulation
(EU) No. 596/2014 (as it forms part of UK law by virtue of The European Union
(Withdrawal) Act 2018) ('MAR'). Upon the publication of this announcement
via a regulatory information service, this inside information is now
considered to be in the public domain.
In addition, market soundings (as defined in MAR) were taken in respect of the
Placing with the result that certain persons became aware of inside
information (as defined in MAR), as permitted by MAR. This inside information
is set out in this announcement being made by the Company today. Therefore,
those persons that received inside information in a market sounding are no
longer in possession of such inside information relating to the Company and
its securities.
PDMR notifications
The below notification made in accordance with the requirements of MAR,
provides further detail:
1. Details of the person discharging managerial responsibilities / person closely
associated
a) Name 1. David Barrett
2. Max Vermorken
3. Garth Palmer
4. Charles Trigg
5. Dean Masefield
2. Reason for the Notification
a) Position/status 1. Executive Chairman
2. Chief Executive Officer
3. Chief Finance Officer
4. Non-Executive Director
5. Deputy Chief Finance Officer
b) Initial notification/amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name SigmaRoc plc
b) LEI 213800Q3CJUERBGD1E44
4. Details of the transaction(s):section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv)each place
where transactions have been conducted
a) Description of the Financial instrument, type of instrument Ordinary Shares of 1p
Identification code GB00BYX5K988
b) Nature of the Transaction Purchase of shares
c) Price(s) and volume(s) Price(s) Volume(s)
1. 54p 1. 265,741
2. 54p 2. 64,815
3. 54p 3. 55,556
4. 54p 4. 37,037
5. 54p 5. 9,259
d) Aggregated information Aggregate volume: 432,408
Aggregated volume /price Aggregate price: 54p
e) Date of the transaction 23 February 2023
f) Place of the transaction London Stock Exchange, AIM
d)
Aggregated information
Aggregated volume /price
Aggregate volume: 432,408
Aggregate price: 54p
e)
Date of the transaction
23 February 2023
f)
Place of the transaction
London Stock Exchange, AIM
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END MSCFZGZZVFVGFZG